A new STAT article highlights major shifts in CVD prevention guidelines, including considering statins as early as age 30 and using updated risk tools. CP3’s Dr. Tim Anderson, interviewed for the article, notes the focus on balancing long-term benefits with risks and identifying high-risk patients earlier.